Entry of generic drugs into the market should cause prices to drop. However, the generic industry has recently taken a page from the brand-name industry, engaging in price gouging and making it increasingly difficult to obtain critical medications, Marc Harrison,…
Pharmacy
As costs continue to mount from opioid litigation, Insys Therapeutics faces the risk of going out of business, according to Bloomberg.
Several drugmakers and pharmacy chains are hard at work responding to the hundreds of lawsuits accusing them of fueling the deadly opioid epidemic in the U.S. While billions of dollars are at stake for these companies if they are found…
Specialty drugmaker Sonoma Pharmaceuticals will reduce its workforce in an effort to slow "cash burn."
In 2018, Abbvie's rheumatoid arthritis drug Humira once again topped the list of best-selling drugs, according to a new analysis published in Nature.
Advertisement
The FDA approved a new generic of valsartan Feb. 12 to help relieve the shortage of the critical blood pressure drug that resulted from a string of recent recalls.
Facing pressure from investors, Rite Aid will replace three of its top executives and shed 400 corporate jobs.
The Senate Finance Committee has invited leaders from five major pharmacy benefit managers to testify at an April 3 hearing about high prescription drug costs in the U.S., according to CNBC.
The pharmacy manager of JNT Pharmacy in Brewster, N.Y., allegedly stole and resold more than $50,000 worth of diabetic test strips, according to the Times Herald-Record.
Pfizer will pay $975,000 to settle allegations that it misled customers with its copay coupon program, according to a STAT news report.